List of Figures
Figure 1: Schematic representation of Amyotrophic Lateral Sclerosis
Figure 2: Pathophysiology of Amyotrophic Lateral Sclerosis
Figure 3: Drug Designations
Figure 4: Total Products for Amyotrophic Lateral Sclerosis
Figure 5: Late Stage Products (Filed and Phase III)
Figure 6: Mid Stage Products (Phase II)
Figure 7: Early Stage Products (Phase I)
Figure 8: Assessment by Monotherapy Products
Figure 9: Assessment by Route of Administration
Figure 10: Assessment by Stage and Route of Administration
Figure 11: Assessment by Molecule Type
Figure 12: Assessment by Stage and Molecule Type
Figure 13: Pre-clinical Stage and Discovery Products
Figure 14: Dormant & Discontinued Products
Figure 15: 7MM, ALS Incident Cases, 2015-2027
Figure 16: 7MM, ALS Type Specific Incident Cases, 2015-2027
Figure 17: 7MM, Age Specific Incidence of ALS, 2015-2027
Figure 18: 7MM, Gender Specific Incidence of ALS, 2015-2027
Figure 19:7MM, ALS Prevalent Cases, 2015-2027
Figure 20: 7MM, ALS Type Specific Prevalent Cases, 2015-2027
Figure 21: 7MM, Age Specific Prevalence of ALS, 2015-2027
Figure 22: 7MM, Gender Specific Prevalence of ALS, 2015-2027
Figure 23: United States, ALS Incident Cases, 2015-2027
Figure 24: United States, ALS Type Specific Incident Cases, 2015-2027
Figure 25:United States, Age Specific Incidence of ALS, 2015-2027
Figure 26: United States, Gender Specific Incidence of ALS, 2015-2027
Figure 27: United States, Race Specific Incidence of ALS, 2015-2027
Figure 28: United States, ALS Prevalent Cases, 2015-2027
Figure 29: United States, ALS Type Specific Prevalent Cases, 2015-2027
Figure 30: United States, Age Specific Prevalence of ALS, 2015-2027
Figure 31: United States, Gender Specific Prevalence of ALS, 2015-2027
Figure 32: United States, Race Specific Prevalence of ALS, 2015-2027
Figure 33: United Kingdom, ALS Incident Cases, 2015-2027
Figure 34: United Kingdom, ALS Type Specific Incident Cases, 2015-2027
Figure 35: United Kingdom, Age Specific Incidence of ALS, 2015-2027
Figure 36: United Kingdom, Gender Specific Incidence of ALS, 2015-2027
Figure 37: United Kingdom, Race Specific Incidence of ALS, 2015-2027
Figure 38: United Kingdom, ALS Prevalent Cases, 2015-2027
Figure 39: United Kingdom, ALS Type Specific Prevalent Cases, 2015-2027
Figure 40: United Kingdom, Age Specific Prevalence of ALS, 2015-2027
Figure 41: United Kingdom, Gender Specific Prevalence of ALS, 2015-2027
Figure 42: United Kingdom, Race Specific Prevalence of ALS, 2015-2027
Figure 43: France, ALS Incident Cases, 2015-2027
Figure 44: France, ALS Type Specific Incident Cases, 2015-2027
Figure 45: France, Age Specific Incidence of ALS, 2015-2027
Figure 46: France, Gender Specific Incidence of ALS, 2015-2027
Figure 47: France, Race Specific Incidence of ALS, 2015-2027
Figure 48: France, ALS Prevalent Cases, 2015-2027
Figure 49: France, ALS Type Specific Prevalent Cases, 2015-2027
Figure 50: France, Age Specific Prevalence of ALS, 2015-2027
Figure 51: France, Gender Specific Prevalence of ALS, 2015-2027
Figure 52: France, Race Specific Prevalence of ALS, 2015-2027
Figure 53: Italy, ALS Incident Cases, 2015-2027
Figure 54: Italy, ALS Type Specific Incident Cases, 2015-2027
Figure 55: Italy, Age Specific Incidence of ALS, 2015-2027
Figure 56: Italy, Gender Specific Incidence of ALS, 2015-2027
Figure 57: Italy, Race Specific Incidence of ALS, 2015-2027
Figure 58: Italy, ALS Prevalent Cases, 2015-2027
Figure 59: Italy, ALS Type Specific Prevalent Cases, 2015-2027
Figure 60: Italy, Age Specific Prevalence of ALS, 2015-2027
Figure 61: Italy, Gender Specific Prevalence of ALS, 2015-2027
Figure 62: Italy, Race Specific Prevalence of ALS, 2015-2027
Figure 63: Spain, ALS Incident Cases, 2015-2027
Figure 64: Spain, ALS Type Specific Incident Cases, 2015-2027
Figure 65: Spain, Age Specific Incidence of ALS, 2015-2027
Figure 66: Spain, Gender Specific Incidence of ALS, 2015-2027
Figure 67: Spain, Race Specific Incidence of ALS, 2015-2027
Figure 68: Spain, ALS Prevalent Cases, 2015-2027
Figure 69: Spain, ALS Type Specific Prevalent Cases, 2015-2027
Figure 70: Spain, Age Specific Prevalence of ALS, 2015-2027
Figure 71: Spain, Gender Specific Prevalence of ALS, 2015-2027
Figure 72: Spain, Race Specific Prevalence of ALS, 2015-2027
Figure 73: Germany, ALS Incident Cases, 2015-2027
Figure 74: Germany, ALS Type Specific Incident Cases, 2015-2027
Figure 75: Germany, Age Specific Incidence of ALS, 2015-2027
Figure 76: Germany, Gender Specific Incidence of ALS, 2015-2027
Figure 77: Germany, Race Specific Incidence of ALS, 2015-2027
Figure 78: Germany, ALS Prevalent Cases, 2015-2027
Figure 79: Germany, ALS Type Specific Prevalent Cases, 2015-2027
Figure 80: Germany, Age Specific Prevalence of ALS, 2015-2027
Figure 81: Germany, Gender Specific Prevalence of ALS, 2015-2027
Figure 82: Germany, Race Specific Prevalence of ALS, 2015-2027
Figure 83: Japan, ALS Incident Cases, 2015-2027
Figure 84: Japan, ALS Type Specific Incident Cases, 2015-2027
Figure 85: Japan, Age Specific Incidence of ALS, 2015-2027
Figure 86: Japan, Gender Specific Incidence of ALS, 2015-2027
Figure 87: Japan, ALS Prevalent Cases, 2015-2027
Figure 88: Japan, ALS Type Specific Prevalent Cases, 2015-2027
Figure 89: Japan, Age Specific Prevalence of ALS, 2015-2027
Figure 90: Japan, Gender Specific Prevalence of ALS, 2015-2027
Figure 91: Global, ALS Incident Cases, 2015-2027
Figure 92: Global, ALS Type Specific Incident Cases, 2015-2027
Figure 93: Global, Age Specific Incidence of ALS, 2015-2027
Figure 94: Global, Gender Specific Incidence of ALS, 2015-2027
Figure 95: Global, ALS Prevalent Cases, 2015-2027
Figure 96: Global, ALS Type Specific Prevalent Cases, 2015-2027
Figure 97: Global, Age Specific Prevalence of ALS, 2015-2027
Figure 98: Global, Gender Specific Prevalence of ALS, 2015-2027
Figure 99: EU5, ALS Incident Cases, 2015-2027
Figure 100: EU5, ALS Type Specific Incident Cases, 2015-2027
Figure 101: EU5, Age Specific Incidence of ALS, 2015-2027
Figure 102: EU5, Gender Specific Incidence of ALS, 2015-2027
Figure 103: EU5, Race Specific Incidence of ALS, 2015-2027
Figure 104: EU5, ALS Prevalent Cases, 2015-2027
Figure 105: EU5, ALS Type Specific Prevalent Cases, 2015-2027
Figure 106: EU5, Age Specific Prevalence of ALS, 2015-2027
Figure 107: EU5, Gender Specific Prevalence of ALS, 2015-2027
Figure 108: RoW, ALS Incident Cases, 2015-2027
Figure 109: RoW, ALS Type Specific Incident Cases, 2015-2027
Figure 110: RoW, Age Specific Incidence of ALS, 2015-2027
Figure 111: RoW, Gender Specific Incidence of ALS, 2015-2027
Figure 112: RoW, Race Specific Incidence of ALS, 2015-2027
Figure 113: RoW, ALS Prevalent Cases, 2015-2027
Figure 114: RoW, ALS Type Specific Prevalent Cases, 2015-2027
Figure 115: RoW, Age Specific Prevalence of ALS, 2015-2027
Figure 116: RoW, Gender Specific Prevalence of ALS, 2015-2027
Figure 117: United States Market Size
Figure 118: Europe Market Size
Figure 119: Japan Market Size
Figure 120: RoW Market Size
Figure 121: Global Market Size

 

List of Tables
Table 1: Drug Designations
Table 2: Total Products for Amyotrophic Lateral Sclerosis
Table 3: Late Stage Products (Filed and Phase III)
Table 4: Mid Stage Products (Phase II)
Table 5: Early Stage Products (Phase I)
Table 6: Assessment by Monotherapy Products
Table 7: Assessment by Combination Products
Table 8: Assessment by Route of Administration
Table 9: Assessment by Stage and Route of Administration
Table 10: Assessment by Molecule Type
Table 11: Assessment by Stage and Molecule Type
Table 12: Pre-clinical and Discovery Stage Products
Table 13: Dormant Products
Table 14: Discontinued Products
Table 15: 7MM, ALS Incident Cases, 2015-2027
Table 16: 7MM, ALS Type Specific Incident Cases, 2015-2027
Table 17: 7MM, Age Specific Incidence of ALS, 2015-2027
Table 18:7MM, Gender Specific Incidence of ALS, 2015-2027
Table 19: 7MM, ALS Prevalent Cases, 2015-2027
Table 20: 7MM, ALS Type Specific Prevalent Cases, 2015-2027
Table 21: 7MM, Age Specific Prevalence of ALS, 2015-2027
Table 22: 7MM, Gender Specific Prevalence of ALS, 2015-2027
Table 23: United States, ALS Incident Cases, 2015-2027
Table 24: United States, ALS Type Specific Incident Cases, 2015-2027
Table 25:United States, Age Specific Incidence of ALS, 2015-2027
Table 26: United States, Gender Specific Incidence of ALS, 2015-2027
Table 27: United States, Race Specific Incidence of ALS, 2015-2027
Table 28: United States, ALS Prevalent Cases, 2015-2027
Table 29: United States, ALS Type Specific Prevalent Cases, 2015-2027
Table 30: United States, Age Specific Prevalence of ALS, 2015-2027
Table 31: United States, Gender Specific Prevalence of ALS, 2015-2027
Table 32: United States, Race Specific Prevalence of ALS, 2015-2027
Table 33: United Kingdom, ALS Incident Cases, 2015-2027
Table 34: United Kingdom, ALS Type Specific Incident Cases, 2015-2027
Table 35: United Kingdom, Age Specific Incidence of ALS, 2015-2027
Table 36: United Kingdom, Gender Specific Incidence of ALS, 2015-2027
Table 37: United Kingdom, Race Specific Incidence of ALS, 2015-2027
Table 38: United Kingdom, ALS Prevalent Cases, 2015-2027
Table 39: United Kingdom, ALS Type Specific Prevalent Cases, 2015-2027
Table 40: United Kingdom, Age Specific Prevalence of ALS, 2015-2027
Table 41: United Kingdom, Gender Specific Prevalence of ALS, 2015-2027
Table 42: United Kingdom, Race Specific Prevalence of ALS, 2015-2027
Table 43: France, ALS Incident Cases, 2015-2027
Table 44: France, ALS Type Specific Incident Cases, 2015-2027
Table 45: France, Age Specific Incidence of ALS, 2015-2027
Table 46: France, Gender Specific Incidence of ALS, 2015-2027
Table 47: France, Race Specific Incidence of ALS, 2015-2027
Table 48: France, ALS Prevalent Cases, 2015-2027
Table 49: France, ALS Type Specific Prevalent Cases, 2015-2027
Table 50: France, Age Specific Prevalence of ALS, 2015-2027
Table 51: France, Gender Specific Prevalence of ALS, 2015-2027
Table 52: France, Race Specific Prevalence of ALS, 2015-2027
Table 53: Italy, ALS Incident Cases, 2015-2027
Table 54: Italy, ALS Type Specific Incident Cases, 2015-2027
Table 55: Italy, Age Specific Incidence of ALS, 2015-2027
Table 56: Italy, Gender Specific Incidence of ALS, 2015-2027
Table 57: Italy, Race Specific Incidence of ALS, 2015-2027
Table 58: Italy, ALS Prevalent Cases, 2015-2027
Table 59: Italy, ALS Type Specific Prevalent Cases, 2015-2027
Table 60: Italy, Age Specific Prevalence of ALS, 2015-2027
Table 61: Italy, Gender Specific Prevalence of ALS, 2015-2027
Table 62: Italy, Race Specific Prevalence of ALS, 2015-2027
Table 63: Spain, ALS Incident Cases, 2015-2027
Table 64: Spain, ALS Type Specific Incident Cases, 2015-2027
Table 65: Spain, Age Specific Incidence of ALS, 2015-2027
Table 66: Spain, Gender Specific Incidence of ALS, 2015-2027
Table 67: Spain, Race Specific Incidence of ALS, 2015-2027
Table 68: Spain, ALS Prevalent Cases, 2015-2027
Table 69: Spain, ALS Type Specific Prevalent Cases, 2015-2027
Table 70: Spain, Age Specific Prevalence of ALS, 2015-2027
Table 71: Spain, Gender Specific Prevalence of ALS, 2015-2027
Table 72: Spain, Race Specific Prevalence of ALS, 2015-2027
Table 73: Germany, ALS Incident Cases, 2015-2027
Table 74: Germany, ALS Type Specific Incident Cases, 2015-2027
Table 75: Germany, Age Specific Incidence of ALS, 2015-2027
Table 76: Germany, Gender Specific Incidence of ALS, 2015-2027
Table 77: Germany, Race Specific Incidence of ALS, 2015-2027
Table 78: Germany, ALS Prevalent Cases, 2015-2027
Table 79: Germany, ALS Type Specific Prevalent Cases, 2015-2027
Table 80: Germany, Age Specific Prevalence of ALS, 2015-2027
Table 81: Germany, Gender Specific Prevalence of ALS, 2015-2027
Table 82: Germany, Race Specific Prevalence of ALS, 2015-2027
Table 83: Japan, ALS Incident Cases, 2015-2027
Table 84: Japan, ALS Type Specific Incident Cases, 2015-2027
Table 85: Japan, Age Specific Incidence of ALS, 2015-2027
Table 86: Japan, Gender Specific Incidence of ALS, 2015-2027
Table 87: Japan, ALS Prevalent Cases, 2015-2027
Table 88: Japan, ALS Type Specific Prevalent Cases, 2015-2027
Table 89: Japan, Age Specific Prevalence of ALS, 2015-2027
Table 90: Japan, Gender Specific Prevalence of ALS, 2015-2027
Table 91: Global, ALS Incident Cases, 2015-2027
Table 92: Global, ALS Type Specific Incident Cases, 2015-2027
Table 93: Global, Age Specific Incidence of ALS, 2015-2027
Table 94: Global, Gender Specific Incidence of ALS, 2015-2027
Table 95: Global, ALS Prevalent Cases, 2015-2027
Table 96: Global, ALS Type Specific Prevalent Cases, 2015-2027
Table 97: Global, Age Specific Prevalence of ALS, 2015-2027
Table 98: Global, Gender Specific Prevalence of ALS, 2015-2027
Table 99: EU5, ALS Incident Cases, 2015-2027
Table 100: EU5, ALS Type Specific Incident Cases, 2015-2027
Table 101: EU5, Age Specific Incidence of ALS, 2015-2027
Table 102: EU5, Gender Specific Incidence of ALS, 2015-2027
Table 103: EU5, Race Specific Incidence of ALS, 2015-2027
Table 104: EU5, ALS Prevalent Cases, 2015-2027
Table 105: EU5, ALS Type Specific Prevalent Cases, 2015-2027
Table 106: EU5, Age Specific Prevalence of ALS, 2015-2027
Table 107: EU5, Gender Specific Prevalence of ALS, 2015-2027
Table 108: RoW, ALS Incident Cases, 2015-2027
Table 109: RoW, ALS Type Specific Incident Cases, 2015-2027
Table 110: RoW, Age Specific Incidence of ALS, 2015-2027
Table 111: RoW, Gender Specific Incidence of ALS, 2015-2027
Table 112: RoW, Race Specific Incidence of ALS, 2015-2027
Table 113: RoW, ALS Prevalent Cases, 2015-2027
Table 114: RoW, ALS Type Specific Prevalent Cases, 2015-2027
Table 115: RoW, Age Specific Prevalence of ALS, 2015-2027
Table 116:RoW, Gender Specific Prevalence of ALS, 2015-2027